Adrenomedullin and central cardiovascular regulation.
Adrenomedullin gene products have been localized to neurons in brain that innervate sites known to be important in the regulation of cardiovascular function. Those sites also have been demonstrated to possess receptors for the peptide and central administrations of adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP) elevate blood pressure and heart rate in both conscious and anesthetized animals. The accumulated evidence points to a role of the sympathetic nervous system in these cardiovascular effects. These sympathostimulatory actions of AM and PAMP have been hypothesized to be cardioprotective in nature and to reflect the central nervous system (CNS) equivalent of the direct cardiostimulatory effects of the peptides in the periphery. This review summarizes the most recent data on the CNS actions of the adrenomedullin gene-derived peptides and suggests future strategies for the elucidation of the physiologic relevance of the already demonstrated, pharmacologic actions of these peptides.
Taylor
M M
MM
Department of Pharmacological and Physiological Science, Saint Louis University, School of Medicine, 1402 South Grand Boulevard, St. Louis, Missouri 63104, USA.
Samson
W K
WK
D053607:Adrenomedullin; D000818:Animals; D001341:Autonomic Nervous System / Q000502:physiology*; D002319:Cardiovascular System / Q000378:metabolism; D002490:Central Nervous System / Q000378:metabolism; D006801:Humans; D010446:Peptide Fragments / Q000502:physiology*; D010455:Peptides / Q000502:physiology*; D011506:Proteins / Q000502:physiology*
D010446:Peptide Fragments; D010455:Peptides; D011506:Proteins; D053607:Adrenomedullin